HEADER TRANSFERASE/TRANSFERASE INHIBITOR 22-AUG-14 4R5W TITLE HUMAN ARTD1 (PARP1) - CATALYTIC DOMAIN IN COMPLEX WITH INHIBITOR TITLE 2 XAV939 COMPND MOL_ID: 1; COMPND 2 MOLECULE: POLY [ADP-RIBOSE] POLYMERASE 1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: CATALYTIC DOMAIN (UNP RESIDUES 662-1011); COMPND 5 SYNONYM: PARP-1, ADP-RIBOSYLTRANSFERASE DIPHTHERIA TOXIN-LIKE 1, COMPND 6 ARTD1, NAD(+) ADP-RIBOSYLTRANSFERASE 1, ADPRT 1, POLY[ADP-RIBOSE] COMPND 7 SYNTHASE 1; COMPND 8 EC: 2.4.2.30; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ADPRT, PARP1, PPOL; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: ROSETTA2(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PNIC-CH KEYWDS ADP-RIBOSYLATION, DNA REPAIR, ADP-RIBOSYL TRANSFERASE, TRANSFERASE- KEYWDS 2 TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR T.KARLBERG,A.G.THORSELL,H.SCHULER REVDAT 3 22-NOV-17 4R5W 1 REMARK REVDAT 2 18-JAN-17 4R5W 1 JRNL REVDAT 1 02-SEP-15 4R5W 0 JRNL AUTH A.G.THORSELL,T.EKBLAD,T.KARLBERG,M.LOW,A.F.PINTO, JRNL AUTH 2 L.TRESAUGUES,M.MOCHE,M.S.COHEN,H.SCHULER JRNL TITL STRUCTURAL BASIS FOR POTENCY AND PROMISCUITY IN JRNL TITL 2 POLY(ADP-RIBOSE) POLYMERASE (PARP) AND TANKYRASE INHIBITORS. JRNL REF J.MED.CHEM. 2016 JRNL REFN ISSN 0022-2623 JRNL PMID 28001384 REMARK 2 REMARK 2 RESOLUTION. 2.84 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.5 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.84 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.46 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 20249 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.195 REMARK 3 R VALUE (WORKING SET) : 0.192 REMARK 3 FREE R VALUE : 0.245 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1013 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.84 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.98 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.22 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2813 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2351 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2672 REMARK 3 BIN R VALUE (WORKING SET) : 0.2345 REMARK 3 BIN FREE R VALUE : 0.2466 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.01 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 141 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5556 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 77 REMARK 3 SOLVENT ATOMS : 11 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 71.39 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 49.28 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.02300 REMARK 3 B22 (A**2) : -8.14950 REMARK 3 B33 (A**2) : 8.12650 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.33000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.371 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.919 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.855 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 5738 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 7750 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 2684 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 154 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 806 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 5738 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 736 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 6293 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.17 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.92 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 3.40 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|661 - A|1013 } REMARK 3 ORIGIN FOR THE GROUP (A): -18.7029 -8.9618 -20.5941 REMARK 3 T TENSOR REMARK 3 T11: -0.1495 T22: -0.0806 REMARK 3 T33: -0.0706 T12: -0.0248 REMARK 3 T13: -0.0042 T23: -0.0249 REMARK 3 L TENSOR REMARK 3 L11: 1.2957 L22: 1.8794 REMARK 3 L33: 1.5505 L12: 0.0418 REMARK 3 L13: -0.0158 L23: -0.0089 REMARK 3 S TENSOR REMARK 3 S11: -0.0035 S12: -0.0532 S13: -0.0273 REMARK 3 S21: 0.1638 S22: -0.0013 S23: 0.0992 REMARK 3 S31: -0.0135 S32: -0.2250 S33: 0.0048 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|661 - B|1017 } REMARK 3 ORIGIN FOR THE GROUP (A): 17.6242 -3.7586 -24.1646 REMARK 3 T TENSOR REMARK 3 T11: -0.0872 T22: -0.0659 REMARK 3 T33: -0.0965 T12: -0.0267 REMARK 3 T13: 0.0310 T23: -0.0179 REMARK 3 L TENSOR REMARK 3 L11: 0.8557 L22: 1.4923 REMARK 3 L33: 1.8068 L12: 0.3139 REMARK 3 L13: -0.0922 L23: -0.7642 REMARK 3 S TENSOR REMARK 3 S11: 0.0655 S12: -0.1099 S13: 0.0335 REMARK 3 S21: 0.1324 S22: -0.0031 S23: -0.0550 REMARK 3 S31: -0.2274 S32: 0.2597 S33: -0.0624 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4R5W COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-AUG-14. REMARK 100 THE DEPOSITION ID IS D_1000086938. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-JUN-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91841 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL (SI-111) REMARK 200 MONOCHROMATOR REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX-225 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20249 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.840 REMARK 200 RESOLUTION RANGE LOW (A) : 48.500 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 3.900 REMARK 200 R MERGE (I) : 0.16800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.84 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.01 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.3 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.92100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 4GV7 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.83 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.66 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 21% PEG-3350, 0.17M AMMONIUM SULFATE, REMARK 280 0.09M BIS-TRIS, 1MM XAV939, PH 5.5, VAPOR DIFFUSION, SITTING REMARK 280 DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 33.83100 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 783 REMARK 465 ASP A 784 REMARK 465 HIS A 1014 REMARK 465 HIS A 1015 REMARK 465 HIS A 1016 REMARK 465 HIS A 1017 REMARK 465 HIS A 1018 REMARK 465 ASP B 783 REMARK 465 ASP B 784 REMARK 465 HIS B 1018 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASN A 980 C - N - CA ANGL. DEV. = 16.1 DEGREES REMARK 500 ASN B 980 C - N - CA ANGL. DEV. = 16.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 939 -60.83 -96.36 REMARK 500 ASN A 980 100.56 76.50 REMARK 500 ASP A 981 78.92 59.92 REMARK 500 ASN B 980 100.68 76.03 REMARK 500 ASP B 981 78.72 59.49 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1102 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1103 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1104 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1105 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE XAV A 1106 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 1101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 1102 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE XAV B 1103 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4UND RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH BMN673 REMARK 900 RELATED ID: 4UXB RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH PJ34 REMARK 900 RELATED ID: 4R6E RELATED DB: PDB DBREF 4R5W A 662 1011 UNP P09874 PARP1_HUMAN 662 1011 DBREF 4R5W B 662 1011 UNP P09874 PARP1_HUMAN 662 1011 SEQADV 4R5W MET A 661 UNP P09874 INITIATING METHIONINE SEQADV 4R5W ALA A 762 UNP P09874 VAL 762 VARIANT SEQADV 4R5W ALA A 1012 UNP P09874 EXPRESSION TAG SEQADV 4R5W HIS A 1013 UNP P09874 EXPRESSION TAG SEQADV 4R5W HIS A 1014 UNP P09874 EXPRESSION TAG SEQADV 4R5W HIS A 1015 UNP P09874 EXPRESSION TAG SEQADV 4R5W HIS A 1016 UNP P09874 EXPRESSION TAG SEQADV 4R5W HIS A 1017 UNP P09874 EXPRESSION TAG SEQADV 4R5W HIS A 1018 UNP P09874 EXPRESSION TAG SEQADV 4R5W MET B 661 UNP P09874 INITIATING METHIONINE SEQADV 4R5W ALA B 762 UNP P09874 VAL 762 VARIANT SEQADV 4R5W ALA B 1012 UNP P09874 EXPRESSION TAG SEQADV 4R5W HIS B 1013 UNP P09874 EXPRESSION TAG SEQADV 4R5W HIS B 1014 UNP P09874 EXPRESSION TAG SEQADV 4R5W HIS B 1015 UNP P09874 EXPRESSION TAG SEQADV 4R5W HIS B 1016 UNP P09874 EXPRESSION TAG SEQADV 4R5W HIS B 1017 UNP P09874 EXPRESSION TAG SEQADV 4R5W HIS B 1018 UNP P09874 EXPRESSION TAG SEQRES 1 A 358 MET LYS SER LYS LEU PRO LYS PRO VAL GLN ASP LEU ILE SEQRES 2 A 358 LYS MET ILE PHE ASP VAL GLU SER MET LYS LYS ALA MET SEQRES 3 A 358 VAL GLU TYR GLU ILE ASP LEU GLN LYS MET PRO LEU GLY SEQRES 4 A 358 LYS LEU SER LYS ARG GLN ILE GLN ALA ALA TYR SER ILE SEQRES 5 A 358 LEU SER GLU VAL GLN GLN ALA VAL SER GLN GLY SER SER SEQRES 6 A 358 ASP SER GLN ILE LEU ASP LEU SER ASN ARG PHE TYR THR SEQRES 7 A 358 LEU ILE PRO HIS ASP PHE GLY MET LYS LYS PRO PRO LEU SEQRES 8 A 358 LEU ASN ASN ALA ASP SER VAL GLN ALA LYS ALA GLU MET SEQRES 9 A 358 LEU ASP ASN LEU LEU ASP ILE GLU VAL ALA TYR SER LEU SEQRES 10 A 358 LEU ARG GLY GLY SER ASP ASP SER SER LYS ASP PRO ILE SEQRES 11 A 358 ASP VAL ASN TYR GLU LYS LEU LYS THR ASP ILE LYS VAL SEQRES 12 A 358 VAL ASP ARG ASP SER GLU GLU ALA GLU ILE ILE ARG LYS SEQRES 13 A 358 TYR VAL LYS ASN THR HIS ALA THR THR HIS ASN ALA TYR SEQRES 14 A 358 ASP LEU GLU VAL ILE ASP ILE PHE LYS ILE GLU ARG GLU SEQRES 15 A 358 GLY GLU CYS GLN ARG TYR LYS PRO PHE LYS GLN LEU HIS SEQRES 16 A 358 ASN ARG ARG LEU LEU TRP HIS GLY SER ARG THR THR ASN SEQRES 17 A 358 PHE ALA GLY ILE LEU SER GLN GLY LEU ARG ILE ALA PRO SEQRES 18 A 358 PRO GLU ALA PRO VAL THR GLY TYR MET PHE GLY LYS GLY SEQRES 19 A 358 ILE TYR PHE ALA ASP MET VAL SER LYS SER ALA ASN TYR SEQRES 20 A 358 CYS HIS THR SER GLN GLY ASP PRO ILE GLY LEU ILE LEU SEQRES 21 A 358 LEU GLY GLU VAL ALA LEU GLY ASN MET TYR GLU LEU LYS SEQRES 22 A 358 HIS ALA SER HIS ILE SER LYS LEU PRO LYS GLY LYS HIS SEQRES 23 A 358 SER VAL LYS GLY LEU GLY LYS THR THR PRO ASP PRO SER SEQRES 24 A 358 ALA ASN ILE SER LEU ASP GLY VAL ASP VAL PRO LEU GLY SEQRES 25 A 358 THR GLY ILE SER SER GLY VAL ASN ASP THR SER LEU LEU SEQRES 26 A 358 TYR ASN GLU TYR ILE VAL TYR ASP ILE ALA GLN VAL ASN SEQRES 27 A 358 LEU LYS TYR LEU LEU LYS LEU LYS PHE ASN PHE LYS THR SEQRES 28 A 358 ALA HIS HIS HIS HIS HIS HIS SEQRES 1 B 358 MET LYS SER LYS LEU PRO LYS PRO VAL GLN ASP LEU ILE SEQRES 2 B 358 LYS MET ILE PHE ASP VAL GLU SER MET LYS LYS ALA MET SEQRES 3 B 358 VAL GLU TYR GLU ILE ASP LEU GLN LYS MET PRO LEU GLY SEQRES 4 B 358 LYS LEU SER LYS ARG GLN ILE GLN ALA ALA TYR SER ILE SEQRES 5 B 358 LEU SER GLU VAL GLN GLN ALA VAL SER GLN GLY SER SER SEQRES 6 B 358 ASP SER GLN ILE LEU ASP LEU SER ASN ARG PHE TYR THR SEQRES 7 B 358 LEU ILE PRO HIS ASP PHE GLY MET LYS LYS PRO PRO LEU SEQRES 8 B 358 LEU ASN ASN ALA ASP SER VAL GLN ALA LYS ALA GLU MET SEQRES 9 B 358 LEU ASP ASN LEU LEU ASP ILE GLU VAL ALA TYR SER LEU SEQRES 10 B 358 LEU ARG GLY GLY SER ASP ASP SER SER LYS ASP PRO ILE SEQRES 11 B 358 ASP VAL ASN TYR GLU LYS LEU LYS THR ASP ILE LYS VAL SEQRES 12 B 358 VAL ASP ARG ASP SER GLU GLU ALA GLU ILE ILE ARG LYS SEQRES 13 B 358 TYR VAL LYS ASN THR HIS ALA THR THR HIS ASN ALA TYR SEQRES 14 B 358 ASP LEU GLU VAL ILE ASP ILE PHE LYS ILE GLU ARG GLU SEQRES 15 B 358 GLY GLU CYS GLN ARG TYR LYS PRO PHE LYS GLN LEU HIS SEQRES 16 B 358 ASN ARG ARG LEU LEU TRP HIS GLY SER ARG THR THR ASN SEQRES 17 B 358 PHE ALA GLY ILE LEU SER GLN GLY LEU ARG ILE ALA PRO SEQRES 18 B 358 PRO GLU ALA PRO VAL THR GLY TYR MET PHE GLY LYS GLY SEQRES 19 B 358 ILE TYR PHE ALA ASP MET VAL SER LYS SER ALA ASN TYR SEQRES 20 B 358 CYS HIS THR SER GLN GLY ASP PRO ILE GLY LEU ILE LEU SEQRES 21 B 358 LEU GLY GLU VAL ALA LEU GLY ASN MET TYR GLU LEU LYS SEQRES 22 B 358 HIS ALA SER HIS ILE SER LYS LEU PRO LYS GLY LYS HIS SEQRES 23 B 358 SER VAL LYS GLY LEU GLY LYS THR THR PRO ASP PRO SER SEQRES 24 B 358 ALA ASN ILE SER LEU ASP GLY VAL ASP VAL PRO LEU GLY SEQRES 25 B 358 THR GLY ILE SER SER GLY VAL ASN ASP THR SER LEU LEU SEQRES 26 B 358 TYR ASN GLU TYR ILE VAL TYR ASP ILE ALA GLN VAL ASN SEQRES 27 B 358 LEU LYS TYR LEU LEU LYS LEU LYS PHE ASN PHE LYS THR SEQRES 28 B 358 ALA HIS HIS HIS HIS HIS HIS HET SO4 A1101 5 HET SO4 A1102 5 HET SO4 A1103 5 HET SO4 A1104 5 HET SO4 A1105 5 HET XAV A1106 21 HET SO4 B1101 5 HET SO4 B1102 5 HET XAV B1103 21 HETNAM SO4 SULFATE ION HETNAM XAV 2-[4-(TRIFLUOROMETHYL)PHENYL]-7,8-DIHYDRO-5H- HETNAM 2 XAV THIOPYRANO[4,3-D]PYRIMIDIN-4-OL FORMUL 3 SO4 7(O4 S 2-) FORMUL 8 XAV 2(C14 H11 F3 N2 O S) FORMUL 12 HOH *11(H2 O) HELIX 1 1 PRO A 666 PHE A 677 1 12 HELIX 2 2 ASP A 678 TYR A 689 1 12 HELIX 3 3 PRO A 697 LEU A 701 5 5 HELIX 4 4 SER A 702 GLN A 722 1 21 HELIX 5 5 SER A 725 ILE A 740 1 16 HELIX 6 6 ASN A 754 GLY A 780 1 27 HELIX 7 7 ASP A 788 LEU A 797 1 10 HELIX 8 8 SER A 808 THR A 821 1 14 HELIX 9 9 GLY A 843 GLN A 853 1 11 HELIX 10 10 ARG A 865 THR A 867 5 3 HELIX 11 11 ASN A 868 GLY A 876 1 9 HELIX 12 12 PRO A 885 TYR A 889 5 5 HELIX 13 13 MET A 900 ASN A 906 1 7 HELIX 14 14 PRO A 958 ASN A 961 5 4 HELIX 15 15 SER A 963 VAL A 967 5 5 HELIX 16 16 ASP A 993 ALA A 995 5 3 HELIX 17 17 PRO B 666 ASP B 678 1 13 HELIX 18 18 ASP B 678 TYR B 689 1 12 HELIX 19 19 PRO B 697 LEU B 701 5 5 HELIX 20 20 SER B 702 GLN B 722 1 21 HELIX 21 21 SER B 725 ILE B 740 1 16 HELIX 22 22 ASN B 754 GLY B 780 1 27 HELIX 23 23 ASP B 788 LEU B 797 1 10 HELIX 24 24 SER B 808 THR B 821 1 14 HELIX 25 25 GLY B 843 GLN B 853 1 11 HELIX 26 26 ARG B 865 THR B 867 5 3 HELIX 27 27 ASN B 868 GLY B 876 1 9 HELIX 28 28 PRO B 885 TYR B 889 5 5 HELIX 29 29 MET B 900 ASN B 906 1 7 HELIX 30 30 PRO B 958 ASN B 961 5 4 HELIX 31 31 SER B 963 VAL B 967 5 5 HELIX 32 32 ASP B 993 ALA B 995 5 3 SHEET 1 A 5 THR A 799 VAL A 803 0 SHEET 2 A 5 TYR A 829 ARG A 841 -1 O LYS A 838 N LYS A 802 SHEET 3 A 5 VAL A 997 PHE A1009 -1 O ASN A1008 N ASP A 830 SHEET 4 A 5 ILE A 916 ALA A 925 -1 N ILE A 919 O LEU A1003 SHEET 5 A 5 ARG A 857 SER A 864 -1 N ARG A 858 O VAL A 924 SHEET 1 B 4 ILE A 895 PHE A 897 0 SHEET 2 B 4 GLU A 988 VAL A 991 -1 O VAL A 991 N ILE A 895 SHEET 3 B 4 SER A 947 GLY A 950 -1 N GLY A 950 O GLU A 988 SHEET 4 B 4 MET A 929 LEU A 932 1 N TYR A 930 O SER A 947 SHEET 1 C 2 THR A 954 PRO A 956 0 SHEET 2 C 2 GLY A 974 SER A 976 -1 O ILE A 975 N THR A 955 SHEET 1 D 5 THR B 799 VAL B 803 0 SHEET 2 D 5 TYR B 829 ARG B 841 -1 O LYS B 838 N LYS B 802 SHEET 3 D 5 VAL B 997 PHE B1009 -1 O LYS B1006 N GLU B 832 SHEET 4 D 5 ILE B 916 ALA B 925 -1 N ILE B 919 O LEU B1003 SHEET 5 D 5 ARG B 857 SER B 864 -1 N ARG B 858 O VAL B 924 SHEET 1 E 4 ILE B 895 PHE B 897 0 SHEET 2 E 4 GLU B 988 VAL B 991 -1 O VAL B 991 N ILE B 895 SHEET 3 E 4 SER B 947 GLY B 950 -1 N GLY B 950 O GLU B 988 SHEET 4 E 4 MET B 929 LEU B 932 1 N TYR B 930 O SER B 947 SHEET 1 F 2 THR B 954 PRO B 956 0 SHEET 2 F 2 GLY B 974 SER B 976 -1 O ILE B 975 N THR B 955 CISPEP 1 VAL A 979 ASN A 980 0 -7.62 CISPEP 2 VAL B 979 ASN B 980 0 -6.74 SITE 1 AC1 6 SER A 702 LYS A 703 ARG A 704 GLU A 772 SITE 2 AC1 6 LYS B 798 GLN B 875 SITE 1 AC2 4 LYS A 903 LEU A 985 TYR A 986 HIS B1016 SITE 1 AC3 4 THR A1011 HIS A1013 ARG B 865 HIS B 909 SITE 1 AC4 3 ARG A 865 HIS A 909 HIS B1013 SITE 1 AC5 4 ASP A 766 ALA A 880 TYR A 889 GLY A 894 SITE 1 AC6 11 ASP A 766 ASN A 767 HIS A 862 GLY A 863 SITE 2 AC6 11 SER A 864 ASN A 868 TYR A 896 PHE A 897 SITE 3 AC6 11 LYS A 903 SER A 904 TYR A 907 SITE 1 AC7 6 LYS A 798 GLN A 875 SER B 702 LYS B 703 SITE 2 AC7 6 ARG B 704 GLU B 772 SITE 1 AC8 3 LYS B 903 LEU B 985 TYR B 986 SITE 1 AC9 10 ASP B 766 ASN B 767 HIS B 862 GLY B 863 SITE 2 AC9 10 SER B 864 ASN B 868 TYR B 896 PHE B 897 SITE 3 AC9 10 SER B 904 TYR B 907 CRYST1 74.525 67.662 91.165 90.00 111.28 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013418 0.000000 0.005226 0.00000 SCALE2 0.000000 0.014779 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011772 0.00000 MASTER 347 0 9 32 22 0 15 6 0 0 0 56 END